Goran Ando

Insider Reports History

Entity
Individual
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Goran Ando:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 13.2K $105K $7.95 Aug 21, 2024 Direct
SELECTA BIOSCIENCES INC Director Stock Option (Right to Buy) 75K $59.3K $0.79 Jan 2, 2023 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 23.6K Jan 5, 2024 Direct

Insider Reports Filed by Goran Ando

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EYPT EyePoint Pharmaceuticals, Inc. Aug 21, 2024 1 $39.8K 4 Aug 21, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 1 $0 4 Jan 9, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2023 2 $0 4 Feb 13, 2023 Director
SELB SELECTA BIOSCIENCES INC Jan 2, 2023 1 $0 4 Jan 4, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Feb 9, 2022 4 $0 4 Feb 11, 2022 Director
SELB SELECTA BIOSCIENCES INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
EYPT EyePoint Pharmaceuticals, Inc. Jun 22, 2021 2 $0 4 Jun 23, 2021 Director